PTEN and breast cancer: The PTEN was significantly downregulated in both the breast cancer samples with upregulation of hsa-miR-92b and the breast cancer samples with deletion of PTEN when compared with the normal cohort (P=9.53 × 10−7 and P=2.93 × 10−16, T-test).